SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-073396
Filing Date
2024-06-20
Accepted
2024-06-20 16:15:25
Documents
13
Period of Report
2024-06-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2417690d1_8k.htm   iXBRL 8-K 39695
  Complete submission text file 0001104659-24-073396.txt   213622

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA apre-20240620.xsd EX-101.SCH 3006
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE apre-20240620_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apre-20240620_pre.xml EX-101.PRE 22353
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2417690d1_8k_htm.xml XML 3684
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 241056401
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)